Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

Thursday 09 Feb 2017 Author: Lisa-Marie Janes

Sinophi Healthcare has backed out of a deal with proton therapy systems developer Advanced Oncotherapy (AVO:AIM), causing the latter’s stock to fall more than 10% on the news. Having previously ordered two systems for cancer treatment, Sinophi failed to seal agreements with hospitals in China. (LMJ)

‹ Previous2017-02-09Next ›